Equitas SFB swings to ₹184 Cr profit as provisions normalise; income up 19% YoY

Equitas Small Finance Bank returned to profit in Q1 FY27 (standalone; the bank publishes no consolidated accounts), posting net profit of ₹183.6 Cr against a ₹223.8 Cr loss in the year-ago quarter. Total income rose 18.9% YoY to ₹2,215.5 Cr, led by interest earned of ₹1,960.4 Cr, while net interest income (interest earned less interest expended) stood at ₹1,029.6 Cr. The headline turnaround is almost entirely a credit-cost story: provisions collapsed to ₹160.7 Cr from the exceptional ₹612.2 Cr booked a year ago, which is what dragged Q1 FY26 into the red. Stripping that out, the cleaner read is pre-provision operating profit of ₹404.7 Cr, up 28.6% YoY — solid, but well short of the optics of a loss-to-profit swing.

Sequentially the print softened. Net profit fell 13.7% QoQ from ₹212.7 Cr and PBT eased 12.3% to ₹244.1 Cr, because provisions climbed 29% QoQ (from ₹124.1 Cr) even as pre-provision profit was essentially flat versus Q4's ₹402.5 Cr. That rise in credit costs is consistent with management's own guidance on the Q4 call, which flagged normalisation of credit costs toward ~1.5% for FY27 from the seasonal Q4 low of 1.11% — so the QoQ profit dip is the guided path playing out, not a fresh deterioration. Asset quality actually improved: GNPA fell to 2.42% (from 2.60% QoQ and 2.92% YoY) and NNPA to 0.71%, with capital adequacy at 19.44%.

The stock went into the print at ₹77.69, up 4.1% over the past month of trading.

For context: this is the second-highest quarterly PAT of the last 6 quarters; revenue is at a 6-quarter high.

Against guidance the quarter is broadly on track. The bank's own quarterly update put gross advances at ₹47,653 Cr, up 26.7% YoY — ahead of the 20%+ FY27 advances-growth target — while quarterly ROA of 0.29% annualises to ~1.16%, just under the 1.2-1.25% full-year goal but early in the year and short of the ~1.5% Q4-exit ambition. No published street consensus was available for this print, which landed the same day as the board meeting; the operational beat on advances is the main external corroboration. Alongside the results the board had earlier approved a capital raise and the MD/CEO reappointment, and KMP/SMP changes were announced in late June — governance actions that frame the growth push but do not bear on this quarter's numbers.